These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31096808)

  • 41. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.
    Selva-O'Callaghan A; Alvarado-Cardenas M; Pinal-Fernández I; Trallero-Araguás E; Milisenda JC; Martínez MÁ; Marín A; Labrador-Horrillo M; Juárez C; Grau-Junyent JM
    Expert Rev Clin Immunol; 2018 Mar; 14(3):215-224. PubMed ID: 29473763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CoQ10 and L-carnitine for statin myalgia?
    DiNicolantonio JJ
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1329-33. PubMed ID: 23190071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statin potency associated with incident diabetes in a real-world evaluation.
    Steen DL; Bhatt DL
    Evid Based Med; 2014 Apr; 19(2):68. PubMed ID: 23990528
    [No Abstract]   [Full Text] [Related]  

  • 45. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
    Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
    Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
    J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations.
    Penson PE; Banach M
    Eur Heart J; 2021 Dec; 42(47):4787-4788. PubMed ID: 34151941
    [No Abstract]   [Full Text] [Related]  

  • 48. Bempedoic acid prevents cardiovascular events in statin-intolerant patients.
    Lim GB
    Nat Rev Cardiol; 2023 May; 20(5):285. PubMed ID: 36944785
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of xanthine oxidase to prevent statin-induced myalgia and rhabdomiolysis.
    Alis R; Sanchis-Gomar F; Risso-Ballester J; Perez-Quilis C; Cortell-Ballester J; Romagnoli M; Blesa JR; Emanuele E
    Atherosclerosis; 2015 Mar; 239(1):38-42. PubMed ID: 25568951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.
    Michalska-Kasiczak M; Sahebkar A; Mikhailidis DP; Rysz J; Muntner P; Toth PP; Jones SR; Rizzo M; Kees Hovingh G; Farnier M; Moriarty PM; Bittner VA; Lip GY; Banach M;
    Int J Cardiol; 2015 Jan; 178():111-6. PubMed ID: 25464233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Statin therapy--for whom?].
    Kahri J; Syvänne M
    Duodecim; 2012; 128(8):811-8. PubMed ID: 22616372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in muscle strength in patients with statin myalgia.
    Panza GA; Taylor BA; Roman W; Thompson PD
    Am J Cardiol; 2014 Oct; 114(8):1215-6. PubMed ID: 25171803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
    Rosenson RS; Miller K; Bayliss M; Sanchez RJ; Baccara-Dinet MT; Chibedi-De-Roche D; Taylor B; Khan I; Manvelian G; White M; Jacobson TA
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):179-186. PubMed ID: 28421332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscle-related side-effects of statins: from mechanisms to evidence-based solutions.
    Taylor BA; Thompson PD
    Curr Opin Lipidol; 2015 Jun; 26(3):221-7. PubMed ID: 25943841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. study helps affirm evidence of statins' muscle-related side effects. Cleveland Clinic researchers explore statin intolerance, making a strong argument on behalf of patients who complained of muscle pain caused by cholesterol drugs.
    Heart Advis; 2016 Jun; 19(6):1. PubMed ID: 27372971
    [No Abstract]   [Full Text] [Related]  

  • 56. Statin myopathy: over-rated and under-treated?
    Maghsoodi N; Wierzbicki AS
    Curr Opin Cardiol; 2016 Jul; 31(4):417-25. PubMed ID: 27258372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators.
    Whayne TF
    Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statin-Associated Side Effects.
    Thompson PD; Panza G; Zaleski A; Taylor B
    J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Statin drug interactions and related adverse reactions: an update.
    Bellosta S; Corsini A
    Expert Opin Drug Saf; 2018 Jan; 17(1):25-37. PubMed ID: 29058944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort.
    Sharma N; Cooper R; Kuh D; Shah I
    Sci Rep; 2017 Jul; 7(1):6578. PubMed ID: 28747665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.